Skip to main content
. 2019 May 2;21(6):591–601. doi: 10.1016/j.neo.2019.04.003

Figure 5.

Figure 5

Epigenetic and genetic alteration between the HPV16 subtypes in terms of (A) the methylation-based immune infiltration score, (B) tumor mutation burden, and (C) predicted number of neoantigens. (D) Oncoprint shows the somatic mutation landscape of MutSigCV-detected SMGs and other differentially mutated genes between the subtypes.